![](/images/graphics-bg.png)
A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
المؤلفون المشاركون
Pecora, Silvia
Alesina, Roberta
Milani, Massimo
المصدر
العدد
المجلد 2012، العدد 2012 (31 ديسمبر/كانون الأول 2012)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-11-09
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Background.
Allergen-specific sublingual immunotherapy (SLIT) is considered a causal treatment of respiratory allergies.
Compliance to the SLIT is an important aspect for a positive clinical outcome.
Study Aim.
To evaluate if compliance with grass Allergy Immunotherapy Tablet (AIT) can be increased by providing an electronic compliance device (CED) (Memozax; a tablet-container with a programmable daily acoustic alarm).
Patients and Methods.
261 patients with grass allergy were enrolled and randomized (1 : 1) to 1-year treatment with AIT (Grazax) using a CED (group A; n=122) or without (Group B, n=139).
Compliance was measured through tablet count at each visit.
Results.
The 12-month compliance, mean (SD), in group A was 83% (21) and 83% (24) in group B.
A total of 81% of patients reported a significant clinical improvement of symptoms after treatment in comparison with the previous year.
No severe adverse reactions were observed in the study.
Conclusion.
Compliance to the treatment with AIT administered for 12 consecutive months is in general good.
The use of CED is not associated with a greater compliance.
AIT treatment was associated with a significant clinical improvement in >80% of patients with a good tolerability and safety profile.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Alesina, Roberta& Milani, Massimo& Pecora, Silvia. 2011. A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis. Journal of Allergy،Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-489395
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Alesina, Roberta…[et al.]. A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis. Journal of Allergy No. 2012 (2012), pp.1-6.
https://search.emarefa.net/detail/BIM-489395
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Alesina, Roberta& Milani, Massimo& Pecora, Silvia. A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis. Journal of Allergy. 2011. Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-489395
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-489395
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)